Benign Prostatic Hyperplasia (Enlarged Prostate) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Trump Health Exam: President Still Taking Hair Loss Drug Even After Research Revealed It Causes Erectile ... - Newsweek



Newsweek
 
Trump Health Exam: President Still Taking Hair Loss Drug Even After Research Revealed It Causes Erectile ... 
Newsweek
It's prescribed for the treatment of androgenetic alopecia and benign prostatic hyperplasia, the medical names for what are more commonly referred to as male pattern baldness and an enlarged prostate, according to the Mayo Clinic. The drug is a hormone ...

and more » 


The benefits of laser therapy for symptoms of an enlarged prostate - New York Daily News



New York Daily News
 
The benefits of laser therapy for symptoms of an enlarged prostate 
New York Daily News
Prostate laser surgery is used to relieve moderate to severe urinary symptoms caused by an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH). With laser therapy, a high-energy laser is used to destroy or remove overgrown ...

 


Prostate cancer: 'Whole' Mediterranean diet could reduce your risk - Medical News Today



Medical News Today
 
Prostate cancer: 'Whole' Mediterranean diet could reduce your risk 
Medical News Today
A study of three diets found that only a high adherence to the whole Mediterranean dietary pattern is linked to lower risk of aggressive prostate cancer.

and more » 


NxThera Announces Three-Year Outcomes Data Demonstrating ... - PR Newswire (press release)



NxThera Announces Three-Year Outcomes Data Demonstrating ... 
PR Newswire (press release)
MAPLE GROVE, Minn., Jan. 3, 2018 /PRNewswire/ -- NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVEŽ) platform technology to treat endourological conditions, announced the three-year outcomes ...

and more » 


Sophiris Bio (SPHS) Given a $6.00 Price Target at HC Wainwright - StockNewsTimes



Sophiris Bio (SPHS) Given a $6.00 Price Target at HC Wainwright 
StockNewsTimes
Sophiris Bio logo Sophiris Bio (NASDAQ:SPHS) has been assigned a $6.00 price objective by research analysts at HC Wainwright in a research note issued to investors on Wednesday. The firm currently has a ?buy? rating on the biopharmaceutical company's ...

and more » 


Prostate enlargement: One in three men over 50 at risk ? BPH symptoms explained - Express.co.uk



Express.co.uk
 
Prostate enlargement: One in three men over 50 at risk ? BPH symptoms explained 
Express.co.uk
If you have these symptoms, Dr Renee recommended seeing a doctor since prostate enlargement could lead to worrying complications. ?You could develop acute urinary retention, where urine can't come out at all,? she warned. ?This is a medical emergency ...

 


NxThera touts 3-year Rez?m trial results ? MassDevice - Mass Device



NxThera touts 3-year Rez?m trial results ? MassDevice 
Mass Device
NxThera today released three-year results from a trial of its Rez?m convective water vapor wave energy system, touting effective and durable relief from lower urinary tract symptoms for patients with benign prostatic hyperplasia. The trial was co ...

and more » 


FDA Grants De Novo Request for PROCEPT BioRobotics ... - Business Wire (press release)



FDA Grants De Novo Request for PROCEPT BioRobotics ... 
Business Wire (press release)
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced that the U.S. Food and Drug Administration (FDA) has granted a De ...

and more » 


Benign Prostatic Hyperplasia (BPH) Drugs Market Growth Rate Analysis and Projections to 2021 considering Sales ... - GEOPOLMonitor



GEOPOLMonitor
 
Benign Prostatic Hyperplasia (BPH) Drugs Market Growth Rate Analysis and Projections to 2021 considering Sales ... 
GEOPOLMonitor
About Benign Prostatic Hyperplasia DrugsUrology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control ...

 


Head-To-Head Analysis: Sophiris Bio (SPHS) and SciClone ... - The Ledger Gazette



Head-To-Head Analysis: Sophiris Bio (SPHS) and SciClone ... 
The Ledger Gazette
Sophiris Bio (NASDAQ: SPHS) and SciClone Pharmaceuticals (NASDAQ:SCLN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations ...

and more »